Caribou Biosciences, Inc.
CRBU- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001619856
No open-market purchases or sales by Caribou Biosciences, Inc. insiders were filed in the last 90 days; 137 institutions reported holding it in 13F filings for Q2 2026, worth $84.8M in total; Maverick Capital is the only superinvestor holding it.
13F holders, Q4 2024
Institutional positions in Caribou Biosciences, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 133
- +5 vs. Q3 2024
- Shares held
- 58.3M
- +5.91M (+11.3%) vs. Q3 2024
- Total value
- $93.1M
- −$10.0M (−9.7%) vs. Q3 2024
- New holders
- 27
- 48 more added
- Sold out
- 22
- 27 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CRBU on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 137 | $84.8M |
| Q1 2026 | 137 | $71.3M |
| Q4 2025 | 124 | $58.8M |
| Q3 2025 | 117 | $87.0M |
| Q2 2025 | 129 | $51.2M |
| Q1 2025 | 131 | $45.8M |
| Q4 2024 | 133 | $93.1M |
| Q3 2024 | 129 | $103.1M |
| Q2 2024 | 140 | $87.6M |
| Q1 2024 | 151 | $343.0M |
| Q4 2023 | 144 | $395.8M |
| Q3 2023 | 126 | $338.5M |
| Q2 2023 | 121 | $185.5M |
| Q1 2023 | 126 | $238.3M |
| Q4 2022 | 133 | $273.8M |
| Q3 2022 | 113 | $456.8M |
| Q2 2022 | 120 | $203.0M |
| Q1 2022 | 104 | $313.2M |
| Q4 2021 | 93 | $464.7M |
| Q3 2021 | 88 | $704.7M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Caribou Biosciences, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bruce & Co., Inc. | 250,000 | $397.5K | 0.13% | −50,000−16.7% | Reduced |
| Nuveen Asset Management, LLC | 330,831 | $526.0K | 0.00% | +63,096+23.6% | Added |
| Jane Street Group, LLC | 340,840 | $541.9K | 0.00% | −309,120−47.6% | Reduced |
| DekaBank Deutsche Girozentrale | 130,000 | $630.0K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 396,367 | $630.2K | 0.00% | +239,049+152.0% | Added |
| Ameriprise Financial Inc | 408,058 | $648.8K | 0.00% | +408,058 | New |
| 72 Investment Holdings, LLC | 474,067 | $753.8K | 1.53% | 00.0% | Unchanged |
| Maverick Capital LtdSuperinvestorMaverick Capital | 652,542 | $1.04M | 0.02% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 680,189 | $1.08M | 0.41% | 00.0% | Unchanged |
| Northern Trust Corp | 714,737 | $1.14M | 0.00% | +23,531+3.4% | Added |
| Pale Fire Capital SE | 734,204 | $1.17M | 0.27% | −700−0.1% | Reduced |
| Charles Schwab Investment Management Inc | 745,726 | $1.19M | 0.00% | +6,196+0.8% | Added |
| Millennium Management LLC | 859,825 | $1.37M | 0.00% | +297,351+52.9% | Added |
| FIL Ltd | 860,666 | $1.37M | 0.00% | 00.0% | Unchanged |
| Point72 Asset Management, L.P. | 1,024,989 | $1.63M | 0.00% | −1,106,429−51.9% | Reduced |
| Goldman Sachs Group Inc | 1,070,536 | $1.70M | 0.00% | +369,644+52.7% | Added |
| Two Sigma Investments, LP | 1,118,696 | $1.78M | 0.00% | +214,239+23.7% | Added |
| Jacobs Levy Equity Management, Inc | 1,208,069 | $1.92M | 0.01% | +1,208,069 | New |
| Two Sigma Advisers, LP | 1,470,700 | $2.34M | 0.01% | +416,600+39.5% | Added |
| FMR LLC | 1,647,205 | $2.62M | 0.00% | +65,712+4.2% | Added |
| State Street Corp | 1,657,561 | $2.64M | 0.00% | +39,318+2.4% | Added |
| Dimensional Fund Advisors LP | 1,732,378 | $2.75M | 0.00% | −321,867−15.7% | Reduced |
| Bank of America Corp | 1,769,293 | $2.81M | 0.00% | −2,800,953−61.3% | Reduced |
| Geode Capital Management, LLC | 1,972,395 | $3.14M | 0.00% | −58,048−2.9% | Reduced |
| Elmwood Wealth Management, Inc. | 2,025,740 | $3.22M | 1.30% | −150,000−6.9% | Reduced |
| Schonfeld Strategic Advisors LLC | 2,113,272 | $3.36M | 0.02% | +467,738+28.4% | Added |
| Kynam Capital Management, LP | 2,406,147 | $3.83M | 0.25% | +50,000+2.1% | Added |
| JPMorgan Chase & Co | 2,495,922 | $3.97M | 0.00% | +2,062,563+475.9% | Added |
| Morgan Stanley | 2,749,597 | $4.37M | 0.00% | +1,551,432+129.5% | Added |
| PFM Health Sciences, LP | 3,876,462 | $6.16M | 0.47% | −430,209−10.0% | Reduced |
| Vanguard Group Inc | 4,565,445 | $7.26M | 0.00% | −52,823−1.1% | Reduced |
| Pfizer Inc | 4,690,431 | $7.46M | 0.29% | +4,690,431 | New |
| BlackRock, Inc. | 6,564,189 | $10.4M | 0.00% | −669,183−9.3% | Reduced |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −594,200−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −237,599−100.0% | Sold out |
| Royce & Associates LP | 0 | $0 | 0.00% | −142,912−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −101,535−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −64,458−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −59,364−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −30,073−100.0% | Sold out |
| Bayesian Capital Management, LP | 0 | $0 | 0.00% | −26,084−100.0% | Sold out |
| China Universal Asset Management Co., Ltd. | 0 | $0 | 0.00% | −17,380−100.0% | Sold out |
| Cornercap Investment Counsel Inc | 0 | $0 | 0.00% | −16,522−100.0% | Sold out |
| Erste Asset Management GmbH | 0 | $0 | 0.00% | −13,900−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −12,195−100.0% | Sold out |
| LPL Financial LLC | 0 | $0 | 0.00% | −10,483−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −10,143−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −7,800−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −6,726−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −3,786−100.0% | Sold out |
| Mirae Asset Global Investments Co., Ltd. | 0 | $0 | 0.00% | −3,268−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −675−100.0% | Sold out |
| Jamison Private Wealth Management, Inc. | 0 | $0 | 0.00% | −188−100.0% | Sold out |
| Comerica Bank | 0 | $0 | 0.00% | −127−100.0% | Sold out |
| Daiwa Securities Group Inc. | 0 | $0 | 0.00% | −176−100.0% | Sold out |
| Raymond James & Associates | – | – | – | – | Not filed |